Financial statements Certus Pharma

Balance sheet of Certus Pharma

Company age:
Age:
10 y. 4 m. 25 d.
Share capital:
Share capital:
20 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of CERTUS PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 6 164 574,74 5 920 980,93 6 403 123,02 7 092 684,90 6 958 849,81 6 278 254,34
A. Fixed assets 270 198,64 244 128,25 197 274,34 162 301,39 188 899,23 142 562,35
B. Current assets 5 894 376,10 5 676 852,68 6 205 848,68 6 930 383,51 6 769 950,58 6 135 691,99
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 6 164 574,74 5 920 980,93 6 403 123,02 7 092 684,90 6 958 849,81 6 278 254,34
A. Equity 870 782,47 1 145 850,06 1 889 367,02 2 262 605,96 2 427 428,75 1 830 685,22
B. Liabilities and provisions for liabilities 5 293 792,27 4 775 130,87 4 513 756,00 4 830 078,94 4 531 421,06 4 447 569,12
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 5 110 631,24 4 608 092,77 4 372 553,34 4 688 884,77 4 298 250,73 4 228 477,89
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.